Tandem Diabetes Care (TNDM) Total Current Liabilities (2013 - 2026)

Tandem Diabetes Care's Total Current Liabilities history runs 14 years deep, the most recent figure standing at $248.0 million for Q1 2026.

• Quarterly Total Current Liabilities fell 13.96% year-over-year to $248.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $248.0 million (down 13.96% YoY) and the FY2025 annual result came in at $242.7 million, down 1.75% from the prior year.
• Total Current Liabilities was $248.0 million for Q1 2026 at Tandem Diabetes Care, up from $242.7 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $288.2 million in Q1 2025 and bottomed at $131.8 million in Q1 2022.
• A 5-year average of $209.5 million and a median of $195.3 million in 2023 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2025 — Total Current Liabilities surged 49.34% — and 2026, when it decreased 13.96%.
• Tandem Diabetes Care's Total Current Liabilities stood at $165.3 million in 2022, then advanced by 18.13% to $195.3 million in 2023, then advanced by 26.52% to $247.0 million in 2024, then dropped by 1.75% to $242.7 million in 2025, then advanced by 2.16% to $248.0 million in 2026.
• Business Quant data shows TNDM's Total Current Liabilities at $248.0 million in Q1 2026, $242.7 million in Q4 2025, and $252.5 million in Q3 2025.